Adileh Ayati

1.5k total citations · 2 hit papers
23 papers, 1.2k citations indexed

About

Adileh Ayati is a scholar working on Organic Chemistry, Pharmacology and Molecular Biology. According to data from OpenAlex, Adileh Ayati has authored 23 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Organic Chemistry, 9 papers in Pharmacology and 5 papers in Molecular Biology. Recurrent topics in Adileh Ayati's work include Synthesis and biological activity (15 papers), Click Chemistry and Applications (9 papers) and Synthesis and Characterization of Heterocyclic Compounds (4 papers). Adileh Ayati is often cited by papers focused on Synthesis and biological activity (15 papers), Click Chemistry and Applications (9 papers) and Synthesis and Characterization of Heterocyclic Compounds (4 papers). Adileh Ayati collaborates with scholars based in Iran, Cyprus and Saudi Arabia. Adileh Ayati's co-authors include Alireza Foroumadi, Saeed Emami, Setareh Moghimi, Ali Asadipour, Abbas Shafiee, Maliheh Safavi, Behjat Pouramiri, Somayeh Salarinejad, Mahsa Toolabi and Hamid Irannejad and has published in prestigious journals such as European Journal of Medicinal Chemistry, Frontiers in Chemistry and Bioorganic Chemistry.

In The Last Decade

Adileh Ayati

22 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recent applications of 1,3-thiazole core structure in the identification of new lead compounds and drug discovery

2015 372 citations Adileh Ayati, Saeed Emami et al. European Journal of Medicinal Chemistry profile →
A review on progression of epidermal growth factor receptor (EGFR) inhibitors as an efficient approach in cancer targeted therapy

2020 278 citations Adileh Ayati, Setareh Moghimi et al. Bioorganic Chemistry profile →

Peers

Adileh Ayati

ONCOL

CTM

PRM

Rabah A.T. Serya Egypt

Saleh Ihmaid Saudi Arabia

Linxiang Zhao China

Zhuang Yang China

Qizheng Yao China

Wufu Zhu China

Zunhua Yang China

Qiu Zhong United States

Xuewei Wu China

A. F. M. Motiur Rahman Saudi Arabia

Rabah A.T. Serya Egypt

Adileh Ayati

671 ×0.7

429 ×1.0

178 ×1.0

ONCOL

91 ×0.7

CTM

67 ×0.6

PRM

Citations per year, relative to Adileh Ayati Adileh Ayati (= 1×) peers Rabah A.T. Serya

Countries citing papers authored by Adileh Ayati

Since Specialization

Citations

This map shows the geographic impact of Adileh Ayati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adileh Ayati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adileh Ayati more than expected).

Fields of papers citing papers by Adileh Ayati

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adileh Ayati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adileh Ayati. The network helps show where Adileh Ayati may publish in the future.

Co-authorship network of co-authors of Adileh Ayati

This figure shows the co-authorship network connecting the top 25 collaborators of Adileh Ayati. A scholar is included among the top collaborators of Adileh Ayati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adileh Ayati. Adileh Ayati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Toolabi, Mahsa, et al.. (2025). Coumarin derivatives as potential anticancer agents: Synthesis, antiproliferative activity, apoptosis, and molecular docking studies. Results in Chemistry. 16. 102442–102442. 1 indexed citations

Valipour, Mehdi, et al.. (2024). Advances in the selective c-MET kinase inhibitors: Application of fused [5,6]-Bicyclic nitrogen-containing cores for anticancer drug design. European Journal of Medicinal Chemistry. 284. 117177–117177. 1 indexed citations

Valipour, Mehdi, et al.. (2023). Recent Applications of Protoberberines as Privileged Starting Materials for the Development of Novel Broad-Spectrum Antiviral Agents: A Concise Review (2017–2023). ACS Pharmacology & Translational Science. 7(1). 48–71. 6 indexed citations

Nadri, Hamid, Setareh Moghimi, Roham Foroumadi, et al.. (2022). Novel 3-aminobenzofuran derivatives as multifunctional agents for the treatment of Alzheimer’s disease. Frontiers in Chemistry. 10. 882191–882191. 6 indexed citations

Toolabi, Mahsa, Fatemeh Safari, Adileh Ayati, et al.. (2022). Synthesis of novel 2‐acetamide‐5‐phenylthio‐1,3,4‐thiadiazole‐containing phenyl urea derivatives as potential VEGFR‐2 inhibitors. Archiv der Pharmazie. 355(3). e2100397–e2100397. 6 indexed citations

Ayati, Adileh, Setareh Moghimi, Mahsa Toolabi, & Alireza Foroumadi. (2021). Pyrimidine-based EGFR TK inhibitors in targeted cancer therapy. European Journal of Medicinal Chemistry. 221. 113523–113523. 83 indexed citations

Anaeigoudari, Akbar, et al.. (2021). Design, Green Synthesis, and Biological Evaluation of New Substituted Tetrahydropyrimidine Derivatives as Acetylcholinesterase Inhibitors. Polycyclic aromatic compounds. 42(8). 5231–5241. 13 indexed citations

Pouramiri, Behjat, et al.. (2021). Green Synthesis and Anticancer Evaluation of Novel Chrysin Hydrazone Derivatives. Polycyclic aromatic compounds. 43(1). 176–189. 4 indexed citations

Toolabi, Mahsa, Mona Khoramjouy, Adileh Ayati, et al.. (2020). Synthesis and radioligand‐binding assay of 2,5‐disubstituted thiadiazoles and evaluation of their anticonvulsant activities. Archiv der Pharmazie. 353(12). e2000066–e2000066. 12 indexed citations

10.

Ayati, Adileh, Setareh Moghimi, Somayeh Salarinejad, et al.. (2020). A review on progression of epidermal growth factor receptor (EGFR) inhibitors as an efficient approach in cancer targeted therapy. Bioorganic Chemistry. 99. 103811–103811. 278 indexed citations breakdown →

11.

Ayati, Adileh, Saeed Emami, Setareh Moghimi, & Alireza Foroumadi. (2019). Thiazole in the Targeted Anticancer Drug Discovery. Future Medicinal Chemistry. 11(15). 1929–1952. 115 indexed citations

12.

Ayati, Adileh, Rezvan Esmaeili, Setareh Moghimi, et al.. (2018). Synthesis and biological evaluation of 4-amino-5-cinnamoylthiazoles as chalcone-like anticancer agents. European Journal of Medicinal Chemistry. 145. 404–412. 39 indexed citations

13.

Ayati, Adileh, Setareh Moghimi, Rezvan Esmaeili, et al.. (2018). Synthesis and biological evaluation of new coumarins bearing 2,4-diaminothiazole-5-carbonyl moiety. European Journal of Medicinal Chemistry. 155. 483–491. 41 indexed citations

14.

Ayati, Adileh, Saeed Emami, & Alireza Foroumadi. (2016). The importance of triazole scaffold in the development of anticonvulsant agents. European Journal of Medicinal Chemistry. 109. 380–392. 111 indexed citations

15.

Ayati, Adileh, Saeed Emami, & Alireza Foroumadi. (2016). ChemInform Abstract: The Importance of Triazole Scaffold in the Development of Anticonvulsant Agents. ChemInform. 47(13).

16.

Ayati, Adileh, Saeed Emami, Ali Asadipour, Abbas Shafiee, & Alireza Foroumadi. (2015). Recent applications of 1,3-thiazole core structure in the identification of new lead compounds and drug discovery. European Journal of Medicinal Chemistry. 97. 699–718. 372 indexed citations breakdown →

17.

Ayati, Adileh, Saeed Emami, Ali Asadipour, Abbas Shafiee, & Alireza Foroumadi. (2015). ChemInform Abstract: Recent Applications of 1,3‐Thiazole Core Structure in the Identification of New Lead Compounds and Drug Discovery. ChemInform. 46(32). 3 indexed citations

18.

Ayati, Adileh & Saeed Emami. (2013). Straightforward synthesis of thiazoline-incorporated chalconoids from phenacyl halides. Molecular Diversity. 17(1). 41–47. 3 indexed citations

19.

Ayati, Adileh, Mehraban Falahati, Hamid Irannejad, & Saeed Emami. (2012). Synthesis, in vitro antifungal evaluation and in silico study of 3-azolyl-4-chromanone phenylhydrazones. DARU Journal of Pharmaceutical Sciences. 20(1). 46–46. 46 indexed citations

20.

Ahangar, Nematollah, et al.. (2011). 1‐[(2‐Arylthiazol‐4‐yl)methyl]azoles as a New Class of Anticonvulsants: Design, Synthesis,In vivoScreening, andIn silicoDrug‐like Properties. Chemical Biology & Drug Design. 78(5). 844–852. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact